【C信诺维涨超57% 触发二次临停】财联社9月18日电，午后近端次新股持续升温，C信诺维扩大涨幅至57%，触发二次临停。资料显示，公司是一家以疾病为导向、聚焦于重大未满足临床需求的创新药公司。
C信诺维涨超57% 触发二次临停
“特别声明：以上作品内容(包括在内的视频、图片或音频)为凤凰网旗下自媒体平台“大风号”用户上传并发布，本平台仅提供信息存储空间服务。
Notice: The content above (including the videos, pictures and audios if any) is uploaded and posted by the user of Dafeng Hao, which is a social media platform and merely provides information storage space services.”